Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

RELMADA THERAPEUTICS, INC. (RLMD) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

RELMADA THERAPEUTICS, INC. (RLMD), most recent 12 months reported: net loss $61.93M. Latest balance sheet on file: liquid cash $217.73M. From SEC filings. Others in Pharmaceutical Preparations: Rapport Therapeutics, Inc. · Rocket Pharmaceuticals, Inc. · REVELATION BIOSCIENCES, INC. · ROCKET ONE INC. · TRANSCODE THERAPEUTICS, INC. · Rein Therapeutics, Inc. · Reviva Pharmaceuticals Holdings, Inc. · REVIUM Rx.

Stock screener

Watchlist